REMEDY received €50,000 through the BOOST programme (Bringing financial support to innOvation and pOrtfolio activitieS increasing impact) to support its participation in PATH2ELMs. This strategic initiative aligns with the goals of the ELMs Strategic Plan and enables active contributions to key portfolio activities and the advancement of Engineered Living Materials (ELMs).
BOOST is a project funded by the European Commission that supports and complements European Innovation Council (EIC) programs such as EIC Pathfinder and EIC Transition.

The PATH2ELMs – Integration of REMEDY into the EIC Pathfinder ELMs Portfolio project integrates REMEDY’s interkingdom microbial ink technology into the EIC Pathfinder Engineered Living Materials (ELMs) portfolio, contributing to all key focus areas: Communication, Technology, Regulation, Path to Market, Environment & Sustainability, and ELSA. REMEDY is represented in the steering committee and all working groups, and will host the 2025 annual ELMs conference at InnoRenew CoE in Izola, Slovenia. Through collaboration with the Technology Council for Advanced Materials and alignment with initiatives such as the New European Bauhaus, PATH2ELMs strengthens the portfolio’s strategic impact. Ongoing efforts include the preparation of a joint MSCA Doctoral Network proposal to train the next generation of researchers in sustainable ELMs for construction, environmental, and health-related applications.

PROJECT PARTNERS

SLOVENIA
website
AUSTRIA
WEBSITE
AUSTRIA
WEBSITE
NETHERLANDS
WEBSITE

PROJECT ACTIVITIES

Portfolio Representation at the Technology Council for Advanced Materials

Dr. Anna Sandak represents the EIC Engineered Living Materials (ELMs) portfolio in the Technology Council for Advanced Materials, contributing to strategic discussions on strengthening Europe’s leadership in advanced materials, innovation uptake and industrial deployment.
The Council supports the objectives of the European Commission’s Advanced Materials for Industrial Leadership initiative, reinforcing Europe’s strategic autonomy and competitiveness

more
European Commission’s Call for Evidence supporting the upcoming Advanced Materials Act

The EIC Engineered Living Materials (ELMs) portfolio contributed to the European Commission’s Call for Evidence supporting the upcoming Advanced Materials Act, aimed at strengthening Europe’s strategic autonomy and competitiveness.
Projects including REMEDY, Bio-HhOST, BIOACTION, Fungateria, LoopOfFun and SUMO highlighted the need for stronger R&I support, industrial scale-up and regulatory readiness.

MORE
Contribution to the EIC ELMs Portfolio ESR Participation in Portfolio Seminars

REMEDY is represented in the EIC Engineered Living Materials (ELMs) Portfolio through participation in the Steering Committee and thematic working groups, including Technology, Regulatory & ELSA, Path to Market, Environment & Sustainability, and Communication.
For the period 2026–2027, REMEDY holds the Chair position of the Steering Committee, contributing to the coordination and strategic direction of the portfolio.

3rd Annual Meeting of the EIC ELMs Portfolio​ESR Participation in Portfolio Seminars

As part of the BOOST initiative supporting ELMs portfolio engagement, REMEDY organized and hosted the 3rd Annual Meeting of the EIC Engineered Living Materials (ELM) Portfolio on 1–2 October 2025 at InnoRenew CoE, Izola.
The two-day event gathered all ELM portfolio projects, researchers, industry partners, and EIC representatives to discuss scientific progress, sustainability, regulatory pathways, commercialization strategies, and communication activities across the portfolio.

MORE
ESR Participation in Portfolio Seminars

Early-career researchers from REMEDY engage in EIC ELMs Portfolio activities through ongoing participation in meetings and knowledge-exchange initiatives, supporting interdisciplinary collaboration and professional development within the ELMs community.

BOOST Funding to Strengthen ELMs Portfolio Engagement

REMEDY has received €50,000 in funding through the BOOST program – Bringing financial support to innOvation and pOrtfolio activitieS increasing impact, to enhance its involvement in EIC-supported research.
This funding supports REMEDY’s participation in PATH2ELMs, a strategic initiative aimed at aligning with the goals of the ELMs Strategic Plan. Through this initiative, REMEDY will actively contribute to key portfolio activities and help advance innovative technologies in the ELMs field. The PATH2ELMs consortium comprises four partners from three EU countries – Slovenia, Austria, and the Netherlands – including: InnoRenew CoE, Tiger Coatings, Graz University of Technology, and Xylhotrade. The initiative is structured into four key phases and will run until 31 March 2027.

This project has received funding from the European Union’s Horizon Europe programme through the BOOST initiative, under grant agreement No 101192038.